Asbestos diseases often surface decades after the exposure that caused them. That long timeline creates a practical problem in litigation: The company responsible may have changed names, sold assets, or gone out of business, and its insurance paperwork may sit in a warehouse or nowhere at all. “Insurance archaeology” describes the work of locating old […]
Month: January 2026
Biomarkers, Genetics, and Modern Causation Evidence in Mesothelioma Cases
Mesothelioma cases often turn on expert testimony about diagnosis and causation: what the disease is, and what caused it. Newer medical tools, including biomarkers and genetic testing, can make that testimony stronger by adding objective support. They can also create new disputes if the defense tries to reframe what the test results mean. This post […]